Paris-based VC firm HCVC just announced the final closing of its second fund, simply called “Fund II.” And the team has managed to raise $75 million (€69 million) so that it can back pre ...

Today, Fuse Vectors announces $5.2 million in pre-seed financing led by HCVC to revolutionize gene therapy development with its cell-free viral vector technology. The funding will accelerate the ...

Paris, May 28, 2025 (GLOBE NEWSWIRE) -- One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects. Biotechnology company kyron.bio today ...

The seed funding round was led by HCVC, with the participation of Verve Ventures, Entrepreneurs First, Saras Capital, and numerous reputable angel investors. The funds will accelerate the ...